人类肝脏模型市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

人类肝脏模型市场按产品类型(2D 模型、3D 模型、片上肝脏等)、应用程序和地理划分

人类肝脏模型市场快照

Human Liver Models Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计全球人类肝脏模型市场在预测期内的复合年增长率为 13.5%。这一增长主要归因于医疗保健研究和开发的增加、肝病患病率的增加以及器官打印技术的进步。此外,预计将越来越关注开发基于动物的模型的替代品和结果的准确性,这将推动市场增长。此外,非脂肪酸肝病的患病率增加,预计导致肝病的饮酒将推动预测期内的市场增长。然而,肝脏模型的高成本以及将肝脏模型纳入现有工作流程的问题预计将阻碍预测期内的市场增长。

报告范围

肝脏是执行重要身体功能的重要器官,例如凝血因子的合成、胆汁的产生、蛋白质的产生和解毒。人类肝脏模型用于研究药物的毒性,并有助于了解药物的作用和肝脏疾病的进展。

By Product Type
2D Models
3D Models
Liver-on-a-Chip
Others
Application
Eduction
Drug Discovery
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

肝脏芯片肝脏模型预计将以显着速度增长

肝脏芯片是能够模拟肝脏基本功能的关键特征的生物工程系统。与其他模型相比,肝脏芯片更简单且更便宜。此外,由于对用于药物发现和开发的动物模型的低成本替代品的需求不断增长,预计该细分市场将以显着的速度增长。肝脏类器官倡议的增加和人体器官建模技术的进步预计将推动整体市场的增长。

此外,在许多药物的开发中,肝脏感染的增加和​​肝脏模型的使用预计将推动预测期内的市场增长。根据疾病控制与预防中心 (CDC) 的数据,美国每年约有 21,000 名男性和 8,000 名女性患上肝癌,约有 16,000 名男性和 8,000 名女性死于该病。此外,世界各地酒精消费量的增加导致肝脏疾病增加了对肝脏模型的需求。

Human Liver Models Market

预计北美将拥有可观的市场份额

由于研发支出的增加、器官模型的创新以及该地区采用创新的潜在疗法,预计北美和欧洲将占据大部分市场份额。此外,肝病患病率的增加以及该地区主要市场参与者的存在预计将在预测期内推动市场增长。由于对该地区发展中国家的研发投资增加,预计亚太地区将扩大其份额。此外,发展医疗保健基础设施和公司专注于开发有望促进区域增长的新疗法。

Human Liver Models Market

竞争格局

全球人体肝脏模型市场适度巩固和竞争。市场参与者正专注于产品创新、新产品发布和区域扩张,以增加其市场份额。在市场上运营的主要市场参与者包括 Emulate, Inc.、InSphero、BioIVT、Organovo Holdings Inc. 和 Mimetas 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Diseases and Geriatric Population

      2. 4.2.2 Increasing Demand For Technologically Advanced Stretchers

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Specialized Stretchers

      2. 4.3.2 Growing Adoption of Home Healthcare

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 2D Models

      2. 5.1.2 3D Models

      3. 5.1.3 Liver-on-a-Chip

      4. 5.1.4 Others

    2. 5.2 Application

      1. 5.2.1 Eduction

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Organovo Holdings Inc.

      2. 6.1.2 BioIVT

      3. 6.1.3 InSphero

      4. 6.1.4 Emulate, Inc.

      5. 6.1.5 Mimetas

      6. 6.1.6 CN Bio

      7. 6.1.7 Cyfuse Biomedical K.K.

      8. 6.1.8 HuREL Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Human Liver Models Market market is studied from 2018 - 2026.

The Human Liver Models Market is growing at a CAGR of 13.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc., Mimetas are the major companies operating in Human Liver Models Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!